This deliverable outlines communication strategies for stakeholder engagement in the SPARC project, ensuring transparency and visibility.
This document is deliverable D9.5 and provides an overview of the communication,dissemination, and visibility activities implemented by the European Alliance forPersonalised Medicine (EAPM) during the early phase of the SPARC project, coveringthe period from November 2025 to January 2026. It documents the initial steps takento establish a coherent and recognisable communication framework for SPARC,ensuring a strong foundation for effective outreach, transparency, and stakeholderengagement throughout the project’s lifecycle.
No takes yet. Share an insight, caveat, or question.
Tomasso et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: